CD28 and head and neck squamous cell carcinoma: We characterized the anti-tumor cytokine response of tumor-bearing and non-tumor-bearing mice after ex vivo restimulation with CD3/CD28 antibodies or IR HNSCC tumor antigen preparations in these models.